Jan 27, 2015 3:36 AM

Swiss drug maker Novartis posts Q4 profit drop

The Associated Press

BERLIN (AP) Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit.

The Basel, Switzerland-based company said Tuesday that fourth quarter net income came in at $1.49 billion, down from $2 billion in the same quarter the year before excluding its blood-transfusion diagnostics unit, which it sold in 2013. Novartis took a one-time charge of $1.1 billion in the quarter connected to the sale of its flu vaccine business.

Year-end profit rose to $10.3 billion in 2014, a 12 percent increase over 2013's $9.6 billion profit excluding the diagnostics unit.

CEO Joseph Jimenez said in 2014 Novartis "delivered solid sales growth with margin expansion, strengthened innovation and advanced our quality and productivity."


--  Dealing with the Disease of Addiction? Click here for help --

More from NH1.com

NH1 News Debates
NH1 News Replay

NH1 on Twitter

NH1 SkyView Cameras

NH1 on Facebook

Check out NH1 News Rail Polls on LockerDome on LockerDome